YC-1 Antagonizes Wnt/β-Catenin Signaling Through the EBP1 p42 Isoform in Hepatocellular Carcinoma

Novel drugs targeting Wnt signaling are gradually being developed for hepatocellular carcinoma (HCC) treatment. In this study, we used a Wnt-responsive Super-TOPflash (STF) luciferase reporter assay to screen a new compound targeting Wnt signaling. 3-(5′-Hydroxymethyl-2′-furyl)-1-benzylindazole (YC-...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Ju-Yun, Shih, Yu-Lueng, Lin, Shih-Ping, Hsieh, Tsai-Yuan, Lin, Ya-Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562864/
https://www.ncbi.nlm.nih.gov/pubmed/31086087
http://dx.doi.org/10.3390/cancers11050661

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562864/
https://www.ncbi.nlm.nih.gov/pubmed/31086087
http://dx.doi.org/10.3390/cancers11050661

Ejemplares similares